Derek Adams, Ph.D.
Board Member
Kalaris Therapeutics, Inc. (KLRS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Derek Adams, Ph.D.
Derek Adams, Ph.D. is recorded as Board Member at Kalaris Therapeutics, Inc. (KLRS). Kalaris Therapeutics, Inc. reported in an 8-K filed March 18, 2025 that Derek Adams, Ph.D. resigned as Board, effective March 18, 2025. Kalaris Therapeutics, Inc. reported in an 8-K filed February 23, 2023 that Derek Adams, Ph.D. was appointed Class I director, effective March 1, 2023.
“Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board and committees of the Board on which they respectively served”
“On February 22, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of AlloVir, Inc. ("AlloVir"), the Board appointed Derek Adams, Ph.D. to the Board, effective March 1, 2023, to fill a newly created vacancy resulting from the retirement of Ansbert Gadicke, M.D.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-03-01–present
-
2023-03-01–2025-03-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kalaris Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew Oxtoby CEO, Board Member
- Diana M. Brainard CEO, Board Member
- Vikas Sinha CEO
- David Hallal Chairman, Board Member
- Brett Hagen CFO
- Liisa Bayko CFO
- Matthew Gall CFO
- Amy Vandekop Chief Accounting Officer
- Anthony Adamis Board Member
- Laurie Keating Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.